MedPath

A study to compare effect of azithromycin versus empirical treatment in acute encephalitis syndrome

Not Applicable
Conditions
Health Condition 1: G049- Encephalitis, myelitis and encephalomyelitis, unspecified
Registration Number
CTRI/2020/05/025270
Lead Sponsor
KUNDAN MITTA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Presence of altered mental status with at least three of the following: fever ( >38 C) lasting for more than 72 hours before or after presentation; generalized or focal seizure not attributable to preexisting seizure disorder; new onset of focal neurological deficit; CSF pleocytosis > 5/cumm; abnormality of brain parenchyma on neuro imaging suggestive of encephalitis that is acute in onset or new from prior studies; abnormality on electroencephalography that is consistent with encephalitis and not attributable to another cause, coma, or inability to talk.

Exclusion Criteria

- Children with prior developmental delay or intellectual disability

- Children with known renal, pulmonary, cardiac or hepatic dysfunction.

- Children with suspected inborn errors of metabolism

- Children with toxic encephalopathy or traumatic brain injury

- Children who have hemorrhagic or ischemic stroke

- Children with clinical and laboratory evidence of multi-organ dysfunction at hospital admission

- Children who have already received treatment other than conventional treatment including Azithromycin or steroids

- Children having high clinical suspicion of bacterial meningitis or TB meningitis

- Children with a contraindication to Azithromycin or albumin

- Children with known hyper coagulable state

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of children who expired (Mortality)Timepoint: during hospital stay upto discharge
Secondary Outcome Measures
NameTimeMethod
1. Proportion of children with significant disability as determined by Liverpool outcome score (LOS) at discharge <br/ ><br>2. Proportion of children with at least one serious adverse event <br/ ><br>3. Degree of impairment in terms of International Classification of Functioning, Disability, and Health-Children and Youth Version (ICF-CY) <br/ ><br>4. Total length of hospital stay in daysTimepoint: AT TIME OF DISCHARGE
© Copyright 2025. All Rights Reserved by MedPath